Stirling Products Limited is a manufacturer and marketer of proprietary and/or patented pharmaceutical products and natural health products for its own interests as well as on a contractual basis for third parties.  Strategically, Stirling Products is positioned to capitalise on the rapidly changing conditions within the global pharmaceutical and health markets.
  
 
The Stirling Products corporate headquarters are in Sydney, Australia and its North American pharmaceutical manufacturing operations are based on Cape Breton, Nova Scotia, Canada.

 



 

Media Releases

  • Pharma Plant Commences Operations  (ASX:STI)
    Apr 2011   10:32 AM
    Healthcare group, Stirling Products Limited (ASX:STI) advises that the Company's first contract manufacturing operations commenced last Friday at its Cape Breton, Nova Scotia high-tech pharmace...read more
  • Share Purchase Plan Advice  (ASX:STI)
    Apr 2011   10:19 AM
    Healthcare group, Stirling Products Limited (ASX:STI) is pleased to offer all eligible shareholders the opportunity to participate in a Share Purchase Plan (“SPP”). The SPP will pro...read more
  • Progress Report  (ASX:STI)
    Apr 2011   10:35 AM
    Stirling Announces: Q1 Progress Summary Strategic Review Proposed TeleMedCare Spinouts Placement Finalisation   Healthcare group, Stirling Products Limited (ASX:STI...read more

Latest Company News


Videos

Contact Information